NT5CP1

Across TCGA pan-cancer cohorts, NT5CP1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated NT5CP1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NT5CP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NT5CP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

KIRC, LUSC, and LGG are the cancer types where NT5CP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.178	0.416	.010	54	view →
LUSC	DFS	Quartile	II,III,IV	0.554	0.755	.012	33	view →
LGG	OS	Tertile	All	0.321	0.470	<.001	32	view →
HNSC	DFS	Tertile	IV	0.518	0.310	.004	31	view →
COAD	DFS	Quartile	II,III,IV	0.312	0.714	.002	27	view →
BRCA	OS	Quartile	III,IV	0.903	0.742	.016	19	view →
READ	OS	Quartile	IV	0.473	0.935	.003	19	view →
UVM	DFS	Quartile	III,IV	0.301	0.705	.011	14	view →
TGCT	DFS	Quartile	II,III,IV	0.518	1.000	.027	12	view →
SKCM	OS	Quartile	II,III,IV	0.563	0.764	.027	10	view →
GBM	DFS	Tertile	All	0.437	0.192	.004	6	view →
CESC	DFS	Quartile	IV	0.805	0.064	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

NT5CP1–KIRC (DFS)

Open the KIRC breakdown →